Equity Research, Broker Reports, and media content on ImmuPharma plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ImmuPharma plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

ImmuPharma plc

Company Profile

  • Personnel
  • Dimitri Dimitriou, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ImmuPharma plc. We currently have 84 research reports from 7 professional analysts.

  • Open: 13.0p
  • Range Today: 12.6/13.7p
  • 52 Week: 7.01/32.2p
  • Daily Volume: 2.2m
  • Daily Liquidity: (1.19%)
  • # Shares: 183.0m
  • Market Cap: £33.7m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
30Nov20 07:00 RNS Total Share Capital Notification
26Nov20 07:00 RNS Grant of Share Options & PDMR dealing
24Nov20 07:00 RNS Conversion of Convertible Security
23Nov20 07:00 RNS Conversion of Convertible Security
20Nov20 07:00 RNS Update : FDA confirms 4 Dec for Type ‘A’ meeting
18Nov20 07:00 RNS Total Share Capital Notification - Replacement
10Nov20 07:00 RNS Update on submission to the FDA
  • Frequency of research reports

     

  • Research reports on

    ImmuPharma plc

  • Providers covering

    ImmuPharma plc